Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Low depth genome sequencing of Dendrocalamus strictus

PROVIDER: PRJNA839537 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19285162_1.fastq.gz	Fastqsanger.gz
	SRR19285162_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Low depth genome sequencing of Dalbergia sissoo

| PRJNA708168 | ENA

Project description:Low depth genome sequencing of Drepanostachyum falcatum

| PRJNA623158 | ENA

Project description:low depth genome sequencing of Rhododendron campanulatum

| PRJNA708185 | ENA

Phylogenomics using low-depth whole genome sequencing: a case study with the olive tribe

Project description:Phylogenomic inference from low-depth sequencing

| PRJEB29600 | ENA

Miscanthus sinensis strain:EF0214 | cultivar:Strictus EF0214

Project description:Miscanthus sinensis Strictus EF0214 genome sequencing

| PRJNA337560 | ENA

Chrysocolaptes strictus

Project description:Chrysocolaptes strictus

| PRJNA920938 | ENA

Dendrocalamus liboensis

Project description:Dendrocalamus liboensis Genome sequencing

| PRJNA978368 | ENA

EpiMethylTag simultaneously detects ATAC-seq or ChIP-seq signals with DNA methylation

Project description:We developed a low input, low sequencing depth method, EpiMethylTag that combines ATAC-seq or ChIP-seq (M-ATAC or M-ChIP) with bisulfite conversion, to simultaneously examine accessibility/TF binding and methylation on the same DNA.

2019-10-01 | GSE129673 | GEO

Project description:Low depth genome sequencing of Hui nationality in China

| PRJNA623469 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data